PoNS therapy shows promise for MS gait deficits
The study, involving 43 patients with mild-to-moderate MS gait deficits, revealed a total mean improvement of 5.00 in the ...
Pharmabiz8 天
Helius Medical Technologies announces first reimbursement by a major healthcare provider ...
Helius Medical Technologies announces first reimbursement by a major healthcare provider, Anthem Blue Cross Blue Shield, for its PoNS Device: Newtown, Pennsylvania Thursday, March ...
来自MSN1 个月
PoNSTEP Study Confirms Long-Term Benefits of PoNS Therapy for MS Patients
The PoNSTEP study involved 43 patients with gait impairments caused by MS who underwent 14 weeks of rehabilitation, combining the Portable Neuromodulation Stimulator (PoNS) device with physical ...
Medscape18 天
Gait Disorder is the Cardinal Sign of Normal Pressure Hydrocephalus: A Case Study
The cardinal sign of NPH is a hypokinetic gait disorder in which the older ... Lt. John J. Fraser, MS PT, is a physical therapist on the USS Enterprise, Norfolk, VA. Cira Fraser, PhD APRN BC ...